Synmosa Biopharma Financial Flexibility Index
Synmosa Biopharma financial flexibility index. Synmosa Biopharma (4114) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of NT$245.19 Million (operating CF NT$185.72 Million minus capex NT$59.46 Million) represents 0% of total liabilities (NT$3.89 Billion). See 4114 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Synmosa Biopharma (2015–2025)
Financial flexibility index of Synmosa Biopharma from 2015 to 2025. Historical Financial Flexibility Index trend for Synmosa Biopharma across 11 annual periods. Check 4114 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Synmosa Biopharma Financial Flexibility Index by Year (2015–2025)
Synmosa Biopharma financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for Synmosa Biopharma. For the full cash flow conversion analysis, see 4114 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$692.71 Million | NT$411.57 Million | NT$3.89 Billion | ▼ -33.7% |
| 2024 | 0.27x | NT$1.05 Billion | NT$780.62 Million | NT$3.91 Billion | ▲ +24.8% |
| 2023 | 0.22x | NT$781.70 Million | NT$511.93 Million | NT$3.63 Billion | ▲ +29.2% |
| 2022 | 0.17x | NT$759.54 Million | NT$630.25 Million | NT$4.55 Billion | ▲ +31.0% |
| 2021 | 0.13x | NT$537.35 Million | NT$444.29 Million | NT$4.22 Billion | ▲ +37.7% |
| 2020 | 0.09x | NT$408.81 Million | NT$254.40 Million | NT$4.42 Billion | ▲ +161.4% |
| 2019 | 0.04x | NT$138.49 Million | NT$-44.88 Million | NT$3.92 Billion | ▼ -67.3% |
| 2018 | 0.11x | NT$330.43 Million | NT$16.00 Million | NT$3.06 Billion | ▲ +169.6% |
| 2017 | 0.04x | NT$141.74 Million | NT$-5.19 Million | NT$3.54 Billion | ▼ -85.2% |
| 2016 | 0.27x | NT$660.40 Million | NT$236.48 Million | NT$2.44 Billion | ▲ +8.9% |
| 2015 | 0.25x | NT$392.86 Million | NT$23.60 Million | NT$1.58 Billion | — |